Symbols

AGMB

AgomAb·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About AGMB

Agomab Therapeutics Nv

Industry

Biological Technology

Established Date

04/13/2017

Listing Date

02/06/2026

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.agomab.com

Security Type

Depository Receipts (Ordinary Shares)

Office address

Posthoflei 1/6 2600 Antwerpen Belgium

Business

Introduction

AgomAb Therapeutics NV was originally incorporated under the laws of Belgium on April 13, 2017 and is a Belgian private limited liability company. The Company is a clinical-stage biopharmaceutical entity developing innovative disease-improving therapies for immunological and inflammatory diseases, with a particular focus on chronic fibrotic diseases with significant unmet medical needs. Its product candidates are designed to target established pathways and use proven models to enhance efficacy while minimizing systemic toxicity, thereby addressing the limitations of previous treatments. Its mission is to create therapies that not only address fibrosis, but also restore organ function, allowing patients to live fuller and healthier lives.